| Imaging with 99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents1 DJ Yang, CG Kim, NR Schechter, A Azhdarinia, DF Yu, CS Oh, JL Bryant, ... Radiology 226 (2), 465-473, 2003 | 220 | 2003 |
| Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis A Azhdarinia, P Ghosh, S Ghosh, N Wilganowski, EM Sevick-Muraca Molecular imaging and biology 14, 261-276, 2012 | 143 | 2012 |
| In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V DJ Yang, A Azhdarinia, P Wu, DF Yu, W Tansey, SK Kalimi, EE Kim, ... Cancer Biotherapy and Radiopharmaceuticals 16 (1), 73-83, 2001 | 136 | 2001 |
| LGR5-targeted antibody–drug conjugate eradicates gastrointestinal tumors and prevents recurrence X Gong, A Azhdarinia, SC Ghosh, W Xiong, Z An, Q Liu, KS Carmon Molecular cancer therapeutics 15 (7), 1580-1590, 2016 | 107 | 2016 |
| Assessment of epidermal growth factor receptor with 99mTc–ethylenedicysteine–C225 monoclonal antibody NR Schechter, DJ Yang, A Azhdarinia, S Kohanim, R Wendt III, CS Oh, ... Anti-cancer drugs 14 (1), 49-56, 2003 | 105 | 2003 |
| Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck NR Schechter, RE Wendt, DJ Yang, A Azhdarinia, WD Erwin, ... Journal of Nuclear Medicine 45 (10), 1683-1687, 2004 | 94 | 2004 |
| Local regional chemotherapy and radiotherapy using in situ hydrogel DJ Yang, DF Yu, A Azhdarinia, TL Lee, EE Kim US Patent 7,008,633, 2006 | 81 | 2006 |
| A peptide probe for targeted brown adipose tissue imaging A Azhdarinia, AC Daquinag, C Tseng, SC Ghosh, P Ghosh, ... Nature communications 4 (1), 2472, 2013 | 80 | 2013 |
| Assessment of therapeutic tumor response using 99mTc-ethylenedicysteine-glucosamine D Yang, M Yukihiro, DF Yu, M Ito, CS Oh, S Kohanim, A Azhdarinia, ... Cancer biotherapy & radiopharmaceuticals 19 (4), 443-456, 2004 | 77 | 2004 |
| Comparison of DOTA and NODAGA as chelators for 64Cu-labeled immunoconjugates SC Ghosh, KL Pinkston, H Robinson, BR Harvey, N Wilganowski, K Gore, ... Nuclear medicine and biology 42 (2), 177-183, 2015 | 73 | 2015 |
| Automated system for formulating radiopharmaceuticals F Mourtada, A Azhdarinia, D Yang, C Oh US Patent 7,586,102, 2009 | 70 | 2009 |
| Imaging prostate cancer lymph node metastases with a multimodality contrast agent MA Hall, S Kwon, H Robinson, PA Lachance, A Azhdarinia, ... The Prostate 72 (2), 129-146, 2012 | 66 | 2012 |
| Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors ES Delpassand, J Sims-Mourtada, H Saso, A Azhdarinia, F Ashoori, ... Cancer biotherapy & radiopharmaceuticals 23 (3), 292-300, 2008 | 66 | 2008 |
| Assessment of antiangiogenic effect using 99mTc-EC-endostatin DJ Yang, KD Kim, NR Schechter, DF Yu, P Wu, A Azhdarinia, JS Roach, ... Cancer Biotherapy and Radiopharmaceuticals 17 (2), 233-246, 2002 | 61 | 2002 |
| Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small … MA Hall, KL Pinkston, N Wilganowski, H Robinson, P Ghosh, ... Journal of Nuclear Medicine 53 (9), 1427-1437, 2012 | 58 | 2012 |
| Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model E Rodenberg, A Azhdarinia, ZWW Lazard, M Hall, SK Kwon, ... Tissue Engineering Part A 17 (19-20), 2487-2496, 2011 | 58 | 2011 |
| Regional Radiochemotherapy Using In Situ Hydrogel A Azhdarinia, DJ Yang, DF Yu, R Mendez, C Oh, S Kohanim, J Bryant, ... Pharmaceutical research 22, 776-783, 2005 | 53 | 2005 |
| Application of Immuno-PET in antibody–drug conjugate development KS Carmon, A Azhdarinia Molecular imaging 17, 1536012118801223, 2018 | 52 | 2018 |
| Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide A Azhdarinia, N Wilganowski, H Robinson, P Ghosh, S Kwon, ... Bioorganic & medicinal chemistry 19 (12), 3769-3776, 2011 | 52 | 2011 |
| Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP B Zhu, G Wu, H Robinson, N Wilganowski, MA Hall, SC Ghosh, ... Molecular imaging and biology 15, 560-568, 2013 | 51 | 2013 |
Servando Hernandez VargasPh.D. Candidate at MD Anderson UTHealth Graduate SchoolVerified email at uth.tmc.edu
